A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease

Residual disease after neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) is related with poor prognosis; however, the risk of recurrence after 3 years from surgery, becomes similar to other breast cancer subtypes indicating that TNBC is composed of tumours of different prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Joseph A, Araujo, Jhajaira, Cardenas, Nadezhda K, Morante, Zaida, Doimi, Franco, Vidaurre, Tatiana, Balko, Justin M, Gomez, Henry L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685288/
https://www.ncbi.nlm.nih.gov/pubmed/29263808
http://dx.doi.org/10.1038/npjgenmed.2015.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685288/
https://www.ncbi.nlm.nih.gov/pubmed/29263808
http://dx.doi.org/10.1038/npjgenmed.2015.15

Ejemplares similares